The Cooper Companies, Inc.

COO ·Healthcare, Medical Devices, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $374.9M $392.3M $294.2M $385.8M $2.94B $238.4M $466.7M $139.9M
Depreciation & Amortization $377.4M $375.1M $367.7M $346.1M $309.3M — $280.8M $275.1M
Depreciation $178.2M $173.9M $181.5M $166.6M $163.2M $149.9M $135.0M $128.4M
Amortization $199.2M $201.2M $186.2M $179.5M $146.1M $137.2M $145.8M $146.7M
Stock-Based Compensation $70.5M $75.1M $62.1M $54.2M $43.8M $37.6M $35.1M $43.2M
Net Cash from Operating Activities $796.1M $709.3M $607.5M $692.4M $738.6M $486.6M $713.2M $668.9M
Investing Activities
Capital Expenditures $362.4M $421.2M $392.5M $242.0M $214.4M $310.4M $292.1M $193.6M
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $-372.9M $-764.6M $-449.0M $-1.83B $-450.3M $-364.5M $-351.3M $-1.52B
Financing Activities
Dividends Paid $0 $0 $3.0M $3.0M $3.0M $3.0M $3.0M $2.9M
Stock Repurchases $290.1M $0 $0 $78.5M $24.8M $47.8M $156.1M $0
Net Cash from Financing Activities $-425.9M $39.2M $-173.9M $1.19B $-311.4M $-95.5M $-351.4M $844.4M
Net Change in Cash $2.9M $-13.2M $-17.7M $42.0M $-20.2M $27.3M $9.3M $-8.6M
Free Cash Flow $433.7M $288.1M $215.0M $450.4M $524.2M $176.2M $421.1M $475.3M
← Newer Page 1 of 3 Older →